Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study
- 1 March 2001
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 357 (9261), 1008-1011
- https://doi.org/10.1016/s0140-6736(00)04237-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung DiseaseArchives of Internal Medicine, 1999
- Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior CitizensArchives of Internal Medicine, 1998
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyAmerican Journal Of Medicine, 1997
- Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–90 epidemicEpidemiology and Infection, 1997
- The Efficacy of Influenza Vaccination in Elderly IndividualsJAMA, 1994
- The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the CommunityThe New England Journal of Medicine, 1994
- Influenza Vaccine Effectiveness in Preventing Hospitalization for Pneumonia in the ElderlyAmerican Journal of Epidemiology, 1992
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineThe New England Journal of Medicine, 1991
- Influenza VaccinationArchives of Internal Medicine, 1991
- Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985–86 immunization programme in Trent, UKVaccine, 1987